Notably, Peripheral Blood Mononuclear Cells (PBMCs) in individuals with treatment-naïve T2DM have demonstrated a heightened state of NLRP3 activation in comparison to healthy controls in response to DAMPS including FFA and IAPP (14). Here, NLRP3 is linked to type 2 diabetes mellitus.